In contrast to Cohort 1 VAX, peak titers in the vaccinated group of Cohort 2 (Cohort 2 VAX) were observed at 12 weeks post-infection (433,067 ± 620,472; Extended Data Table 2), following a single dose of α-GC+KEX1. The gene discussed is GC; the disease is infection.